NM_003055.3:c.-192C>T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003055.3(SLC18A3):c.-192C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0618 in 538,832 control chromosomes in the GnomAD database, including 2,366 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.069   (  768   hom.,  cov: 33) 
 Exomes 𝑓:  0.059   (  1598   hom.  ) 
Consequence
 SLC18A3
NM_003055.3 5_prime_UTR
NM_003055.3 5_prime_UTR
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.468  
Publications
7 publications found 
Genes affected
 SLC18A3  (HGNC:10936):  (solute carrier family 18 member A3) This gene is a member of the vesicular amine transporter family. The encoded transmembrane protein transports acetylcholine into secretory vesicles for release into the extracellular space. Acetylcholine transport utilizes a proton gradient established by a vacuolar ATPase. This gene is located within the first intron of the choline acetyltransferase gene. [provided by RefSeq, Jul 2008] 
 CHAT  (HGNC:1912):  (choline O-acetyltransferase) This gene encodes an enzyme which catalyzes the biosynthesis of the neurotransmitter acetylcholine. This gene product is a characteristic feature of cholinergic neurons, and changes in these neurons may explain some of the symptoms of Alzheimer's disease. Polymorphisms in this gene have been associated with Alzheimer's disease and mild cognitive impairment. Mutations in this gene are associated with congenital myasthenic syndrome associated with episodic apnea. Multiple transcript variants encoding different isoforms have been found for this gene, and some of these variants have been shown to encode more than one isoform. [provided by RefSeq, May 2010] 
CHAT Gene-Disease associations (from GenCC):
- congenital myasthenic syndrome 6Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- presynaptic congenital myasthenic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85). 
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.226  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0685  AC: 10429AN: 152158Hom.:  751  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
10429
AN: 
152158
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.0591  AC: 22830AN: 386562Hom.:  1598  Cov.: 5 AF XY:  0.0591  AC XY: 11706AN XY: 198178 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
22830
AN: 
386562
Hom.: 
Cov.: 
5
 AF XY: 
AC XY: 
11706
AN XY: 
198178
show subpopulations 
African (AFR) 
 AF: 
AC: 
494
AN: 
8330
American (AMR) 
 AF: 
AC: 
2979
AN: 
10232
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
481
AN: 
11612
East Asian (EAS) 
 AF: 
AC: 
5801
AN: 
25002
South Asian (SAS) 
 AF: 
AC: 
1885
AN: 
22268
European-Finnish (FIN) 
 AF: 
AC: 
1116
AN: 
27974
Middle Eastern (MID) 
 AF: 
AC: 
95
AN: 
1808
European-Non Finnish (NFE) 
 AF: 
AC: 
8353
AN: 
256248
Other (OTH) 
 AF: 
AC: 
1626
AN: 
23088
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.516 
Heterozygous variant carriers
 0 
 1066 
 2133 
 3199 
 4266 
 5332 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 160 
 320 
 480 
 640 
 800 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0687  AC: 10464AN: 152270Hom.:  768  Cov.: 33 AF XY:  0.0734  AC XY: 5464AN XY: 74444 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
10464
AN: 
152270
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
5464
AN XY: 
74444
show subpopulations 
African (AFR) 
 AF: 
AC: 
2535
AN: 
41570
American (AMR) 
 AF: 
AC: 
3562
AN: 
15304
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
131
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
1151
AN: 
5136
South Asian (SAS) 
 AF: 
AC: 
421
AN: 
4834
European-Finnish (FIN) 
 AF: 
AC: 
379
AN: 
10620
Middle Eastern (MID) 
 AF: 
AC: 
7
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
2093
AN: 
68014
Other (OTH) 
 AF: 
AC: 
179
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 508 
 1015 
 1523 
 2030 
 2538 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 102 
 204 
 306 
 408 
 510 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
620
AN: 
3474
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.